期刊文献+

心脉隆联合阿托伐他汀治疗慢性心衰患者的疗效观察 被引量:3

Effect of Xinmailong combined with atorvastatin on patients with chronic heart failure
下载PDF
导出
摘要 目的:观察心脉隆联合阿托伐他汀对慢性心衰患者血浆BNP水平及心功能的影响。方法:92例慢性心衰患者随机分为两组,对照组给予阿托伐他汀治疗,观察组在对照组基础上联合心脉隆治疗。比较两组疗效、血浆CRP和BNP水平及心功能。结果:治疗后,观察组总有效率、LVEF高于对照组,CRP、BNP、LVDD低于对照组,差异均具有统计学意义(P<0.05)。结论:心脉隆联合阿托伐他汀治疗能有效改善慢性心衰患者心功能,降低血清BNP,提高治疗效果。 Objective: To observe the effect of Xinmailong combined with atorvastatin on plasma BNP level and cardiac function in patients with chronic heart failure. Methods: 92 patients with chronic heart failure were divided into two groups randomly. The control group was treated with atorvastatin,and the observation group was treated with Xinmailong on the basis of the control group. The efficacy,plasma CRP and BNP levels and cardiac function were compared between the two groups. Results: After treatment,the total effective rate and the LVEF of the observation group were higher than those of the control group,while the LVDD,CRP and BNP were lower than those in the control group. The differences were statistically significant( P〈0.05). Conclusion: Xinmailong combined with atorvastatin can effectively improve cardiac function,reduce serum BNP and improve therapeutic effect in patients with chronic heart failure.
作者 刘群 LIU Qun(Department of the First Internal Medicine, Luoshan Hospital of Traditional Chinese Medicine, Luoshan 464200, China)
出处 《华夏医学》 CAS 2018年第5期96-99,共4页 Acta Medicinae Sinica
关键词 慢性心衰 心脉隆 阿托伐他汀 血浆BNP水平 心功能 chronic heart failure Xinmailong atorvastatin plasma BNP level cardiac function
  • 相关文献

参考文献10

二级参考文献95

  • 1陈树.糖尿病与心力衰竭的研究及进展[J].中国医学前沿杂志(电子版),2012,4(3):31-35. 被引量:8
  • 2胡经文,冯玲凤,阮慧琴,李小妹.慢性心力衰竭患者睡眠质量及其影响因素调查分析[J].护理学杂志(综合版),2006,21(2):23-25. 被引量:25
  • 3王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 4Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 5Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 6Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 7Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 8Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 9Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 10Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.

共引文献3766

同被引文献33

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部